Specifically, Trump calls for a four-year extension of the period during which small-molecule prescription drugs are exempt from price negotiations with Medicare. Under the Inflation Reduction Act, small-molecule drugs—which are typically taken in pill form and represent 90% of medications currently in circulation—are not subject to the price negotiation process until at least nine years after their Food and Drug Administration approval date.
You must log in or register to comment.
That 4 year number is highly suspect
“caved” I don’t think that’s the word yo use when everything is going according to their plan.